PDENs inhibited tumor cell viability, but provided no inhibitory effects on normal cells. PDEN promotes Bad and Bax genes, and reduces Survivin and Bcl-xL in tumor cells, thus inducing TRAIL-induced cell death and dampening tumor growth. This evidence concerns the gene BCL2L1 and neoplasm.